CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Wells Fargo Initiates Madrigal Pharmaceuticals at Overweight With $685 Price Target

Positive
AI Analysis

Summary

Wells Fargo initiated coverage of Madrigal Pharmaceuticals with an Overweight rating and $685 price target.

Importance:2/10
Sentiment:
0.60
analyst_ratingequity_researchprice_target
Related Companies

Read the original article

Published by yahoo_finance on July 27, 2026 12:12 PM

Read Original